Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 580 participants.
Also called NCT06120725
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 580 participants
- Sponsor
- Registry
-
NCT06120725
-
- Other papers using this trial's data
- Ticagrelor Versus Clopidogrel in Acute Large-Vessel Ischemic Stroke: A Randomized Controlled Single-Blinded Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Egypt
- Registry status
- Completed
Technical summary
Registry record NCT06120725. Randomized; double masking; primary purpose treatment. Start 2021-09-01 (actual); primary completion 2023-09-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke
- Condition
- Ischemic Stroke
- Intervention (Drug)
- Ticagrelor 90 MG
- Intervention (Drug)
- Clopidogrel
- Lead sponsor
- Kafrelsheikh University
Record details
- Record id
cardio:ct-nct06120725- Content hash
fd428d370fd301c109888fbad88970c036434a14236e700351923419cf8962c8